<DOC>
	<DOCNO>NCT02605837</DOCNO>
	<brief_summary>A study adolescent adult eosinophilic esophagitis ( EoE ) measure histologic response determine reduction dysphagia achieve .</brief_summary>
	<brief_title>A Placebo- Controlled Study Adolescents Adults With Eosinophilic Esophagitis ( EoE ) Measuring Histologic Response Determine Reduction Dysphagia Achieved</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Planned duration screen period : 36 week , plan duration treatment period : 16 week , plan duration safety followup period : 4 week</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>